Health Care: Drugs

Discovery Laboratories Inc (DSCO: NASDAQ)

$0.65 -0.0132 | -1.99%
07/07/15 - 09:30 AM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 2.84M 388.00K 195.00K 582.00K
Cost of Sales 2.67M 517.00K 0.00 0.00
Gross Operating Profit 164.00K -129.00K 195.00K 582.00K
Selling, General, and Administrative Expenses 16.73M 16.72M 16.44M 7.86M
Research & Development 26.69M 27.66M 21.57M 17.23M
Operating Income before D & A (EBITDA) -43.26M -44.51M -37.82M -24.51M
Depreciation & Amortization 2.77M 1.24M 1.15M 1.23M
Interest Income 6.00K 3.00K 6.00K 13.00K
Other Income - Net 3.79M 761.00K 555.00K 3.56M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -42.23M -44.98M -38.41M -22.17M
Interest Expense 4.60M 1.47M 57.00K 26.00K
Pre-Tax Income -46.82M -46.46M -38.46M -22.20M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -44.06M -45.22M -37.32M -20.96M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -44.06M -45.22M -37.32M -20.96M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -44.06M -45.22M -37.32M -20.96M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-44.06M -45.22M -37.32M -20.96M
Preferred Dividends
Net Income Available To Common -44.06M -45.22M -37.32M -20.96M
Basic EPS from Continuing Ops. -0.52 -0.82 -0.95 -0.93
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.52 -0.82 -0.95 -0.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.52 -0.82 -0.95 -0.93
Basic Normalized Net Income/Share -0.52 -0.82 -0.95 -0.93
EPS fr Continuing Ops. -0.52 -0.82 -0.95 -0.93
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.52 -0.82 -0.95 -0.93
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.04 0.00 0.00 0.00
EPS, Total -0.56 -0.82 -0.95 -0.93
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.52 -0.82 -0.95 -0.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DSCO

Latest DSCO Headlines from TheStreet

More Financial News for DSCO

Press Releases for DSCO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter